About Quantumcyte
Quantumcyte is a company based in Sunnyvale (United States) founded in 2013 by Bidhan Chaudhuri and John Butler. Quantumcyte has raised $1.3 million across 2 funding rounds from investors including IndieBio. Quantumcyte offers products and services including QCPRECISE™ Platform and Sample Processing Service. Quantumcyte operates in a competitive market with competitors including Reaction Biology, ImmunoSCAPE, Kiyatec, Cellply and PhenoVista, among others.
- Headquarter Sunnyvale, United States
- Founders Bidhan Chaudhuri, John Butler
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.3 M (USD)
in 2 rounds
-
Latest Funding Round
$1.05 M (USD), Seed
Aug 15, 2023
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Quantumcyte
Quantumcyte offers a comprehensive portfolio of products and services, including QCPRECISE™ Platform and Sample Processing Service.
Increases nucleic acid purity from biopsies for reliable multi-omic applications.
Handles tissue samples to deliver purified DNA or RNA for genomics.
People of Quantumcyte
Unlock access to complete
Unlock access to complete
Funding Insights of Quantumcyte
Quantumcyte has successfully raised a total of $1.3M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.05 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Quantumcyte
Quantumcyte has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IndieBio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech startups are accelerated through IndieBio's focused programs.
|
Locked | Locked | Locked |
Investor details for Quantumcyte
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Quantumcyte
Investment portfolio details for Quantumcyte
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Quantumcyte
Detailed financials for Quantumcyte
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Quantumcyte Comparisons
Peer comparison for Quantumcyte
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Quantumcyte
Quantumcyte operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Reaction Biology, ImmunoSCAPE, Kiyatec, Cellply and PhenoVista, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling
|
|
| Locked | Locked | Locked |
High-dimensional immune profiling services are delivered via proprietary platform.
|
|
| Locked | Locked | Locked |
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
|
|
| Locked | Locked | Locked |
Developer of in-vitro diagnostic products for the detection of cancer
|
|
| Locked | Locked | Locked |
A CRO that provides phenotypic assay development and screening services.
|
|
| Locked | Locked | Locked |
Real-time cell analyzers are developed for oxygen consumption monitoring.
|
Detailed competitors of Quantumcyte
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Quantumcyte
Complete news archive for Quantumcyte
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quantumcyte
Quantumcyte was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Quantumcyte is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
John Butler is the current CEO of Quantumcyte. They have also founded this company.
Quantumcyte is a funded company, having raised a total of $1.3M across 2 funding rounds to date.
Quantumcyte was founded in 2013 and is headquartered in Sunnyvale, United States. Operations are centered in the biotechnology sector, where drug assay systems for cancer treatment are developed. These systems support evaluation of therapeutic compounds in research settings. The company is led by co-founders John Butler as CEO and Bidhan Chaudhuri as CTO. Focus remains on advancing assay technologies for oncology applications within the U.S. market.
Quantumcyte's top competitors include ImmunoSCAPE, CytoTronics and Kiyatec.
Quantumcyte offers QCPRECISE™ Platform and Sample Processing Service.
Quantumcyte has 1 investor. Key investors include IndieBio.